Why Cempra Inc. Got Crushed Again

Image source: Getty Images.

Continue Reading Below

What happened

After falling 21% on FridayCempra (NASDAQ: CEMP) fell another 61% today after the U.S. Food and Drug Administration released briefing documents expressing concerns over the safety of Cempra's lead pneumonia antibiotic, solithromycin.

Continue Reading Below

So what

<3>More From Fool.com